Jeffrey Scharfstein

Jeffrey Scharfstein

Partner

 

Jeffrey is super communicative with clients, practical, and pragmatic.
Client quoted in Chambers USA
About

Jeffrey Scharfstein advises US and international clients on a broad range of public and private merger & acquisition (M&A) matters. His experience includes take-privates, investments, joint ventures, carve-outs, de-SPACs and other significant transactions. He also represents private equity firms on a full range of transactions, including acquisitions and dispositions of investments, leveraged buyouts and minority investments.

Bar admissionsNew YorkTexas

EXPERIENCE

Selected Transactions:
  • PROS Holdings (NYSE: PRO) in its pending sale to Thoma Bravo for $1.4 billion
  • Tito’s Handmade Vodka in its acquisition of a majority stake in Lalo Tequila
  • SolarWinds Corporation (NYSE: SWI) in its sale to Turn/River Capital for $4.4 billion
  • Silicon Labs (Nasdaq: SLAB) in the sale to Skyworks Solutions (NASAQ: SWKS) of its infrastructure and automotive business for $2.75 billion
  • Luminex Corporation (NASDAQ: LMNX) in its sale to an Italian publicly traded company for $1.8 billion
  • Alimera Sciences (NASDAQ: ALIM) in its sale to ANI Pharmaceuticals (NASDAQ: ANIP) for approximately $430 million
  • Aetna (NYSE: AET) in its sale to CVS Health (NYSE: CVS) for $69 billion and related DOJ-mandated divestiture
  • Silver Spike Acquisition Corp. (NASDAQ: SSPK), a special purpose acquisition vehicle, in its $1.5 billion combination with WMH Holdings
  • Emerson Electric (NYSE: EMR) in its $3.1 billion acquisition of the valves and controls business of Pentair and a related FTC-mandated divestiture
  • Symphony Technology Group-led consortium in its $2.1 billion acquisition of the RSA software security business from Dell Technologies
  • A financial holding company in its sale of its ownership interest in an asset manager for consideration in excess of $2 billion
  • Lionheart III Corp, a special purpose acquisition company, in its $360 million merger with Security Matters Limited, a publicly traded company on the Australian Securities Exchange
  • N-able, Inc. (NYSE: NABL) in its acquisition of Adlumin, Inc. for approximately $270 million
  • Peak Bio (OTC: PKBO) in its merger of equals with Akari Therapeutics, Plc (NASDAQ: AKTX)
  • Q2 (Nasdaq: QTWO) in its acquisition of ClickSWITCH
  • RateGenius in its business combination with AUTOPAY and formation of The Savings Group
  • Peak Rock Capital and its portfolio company, Ziyad Brothers, in various transactions
  • Safeguard Global in its acquisition of Global Upside Corporation
  • BoomTown in its sale to Inside Real Estate
  • Netwrix in its strategic investment from Centerbridge Partners
  • Echo Investment Capital and its affiliates in various transactions
  • Tailwind Capital and its portfolio companies in connection with various private equity acquisitions and investments
  • ORIX Capital Partners in connection with various private equity acquisitions and investments
  • ECI Telecom Group in its merger with Ribbon Communications
  • Signify Health (NYSE: SGFY) in connection with various strategic matters, including acquisitions and commercial arrangements
  • Pattern Energy in connection with its acquisition of renewable energy projects and related joint ventures
  • Various financial advisor engagements, including representing Morgan Stanley, Dyal and Evercore as advisors to Bristol Myers Squibb in connection with its $74 billion acquisition of Celgene

Awards

Chambers USA

  • Up and Coming, Texas: Austin and Surrounds Corporate/M&A, (2024 — 2025)
Education
  • J.D., Harvard Law School, 2015
    cum laude
  • B.A., Columbia University, 2011
    magna cum laude
    Phi Beta Kappa

Media Mentions

Memberships And Affiliations

  • Chair, Austin Bar Association, Technology Section